210 related articles for article (PubMed ID: 9415870)
21. [Crucial tasks of pharmacologists of the USSR in accelerating scientific and technological progress].
Val'dman AV
Farmakol Toksikol; 1986; 49(6):5-15. PubMed ID: 3817145
[No Abstract] [Full Text] [Related]
22. Back to the future: driving innovation in drug development.
Wagner JA
Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681
[No Abstract] [Full Text] [Related]
23. [Drug discovery based on genome sciences and rational drug design].
Itai A
Tanpakushitsu Kakusan Koso; 2001 Dec; 46(16 Suppl):2630-4. PubMed ID: 11802442
[No Abstract] [Full Text] [Related]
24. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
25. Drug watch 2006: new frontiers.
Wooten JM
RN; 2006 Mar; 69(3):36-40; quiz 41. PubMed ID: 16579158
[No Abstract] [Full Text] [Related]
26. [Perspectives in pharmaceutical innovation after 1980].
Plánicka K
Cesk Farm; 1981 Mar; 30(2):41-5. PubMed ID: 7237589
[No Abstract] [Full Text] [Related]
27. Antibacterial drug discovery: is small pharma the solution?
Boggs AF; Miller GH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
[TBL] [Abstract][Full Text] [Related]
28. Optimizing the impact of genomics on drug discovery and development.
Crooke ST
Nat Biotechnol; 1998 May; 16 Suppl():29-30. PubMed ID: 9591260
[No Abstract] [Full Text] [Related]
29. In vivo we trust.
Frantz S
Nat Rev Drug Discov; 2003 Jun; 2(6):501. PubMed ID: 12790154
[No Abstract] [Full Text] [Related]
30. Genomics in drug discovery: the best things come to those who wait.
Bansal AT; Barnes MR
Curr Opin Drug Discov Devel; 2008 May; 11(3):303-11. PubMed ID: 18428083
[TBL] [Abstract][Full Text] [Related]
31. [The progress of pharmacology and the therapeutic revolution].
Penna M
Rev Med Chil; 1988 Nov; 116(11):1201-6. PubMed ID: 3267905
[No Abstract] [Full Text] [Related]
32. Antibacterial discovery and development--the failure of success?
Fernandes P
Nat Biotechnol; 2006 Dec; 24(12):1497-503. PubMed ID: 17160049
[TBL] [Abstract][Full Text] [Related]
33. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical research and development: what do we get for all that money?
Light DW; Lexchin JR
BMJ; 2012 Aug; 345():e4348. PubMed ID: 22872694
[No Abstract] [Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug development.
Kern SE; Stanski DR
Clin Pharmacol Ther; 2008 Jul; 84(1):153-7. PubMed ID: 18463623
[TBL] [Abstract][Full Text] [Related]
36. Can open-source R&D reinvigorate drug research?
Munos B
Nat Rev Drug Discov; 2006 Sep; 5(9):723-9. PubMed ID: 16915233
[TBL] [Abstract][Full Text] [Related]
37. Improved early clinical development through human microdosing studies.
Wilding IR; Bell JA
Drug Discov Today; 2005 Jul; 10(13):890-4. PubMed ID: 15993808
[No Abstract] [Full Text] [Related]
38. Sulfation through the looking glass--recent advances in sulfotransferase research for the curious.
Coughtrie MW
Pharmacogenomics J; 2002; 2(5):297-308. PubMed ID: 12439736
[TBL] [Abstract][Full Text] [Related]
39. Implications of pharmacogenomics for drug development.
Kirk RJ; Hung JL; Horner SR; Perez JT
Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
[TBL] [Abstract][Full Text] [Related]
40. [Biomedical research: cost-benefit analysis].
Huygelen C
Verh K Acad Geneeskd Belg; 1992; 54(6):599-610. PubMed ID: 1296405
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
